Adiposity, hypertension and weight management behaviours in Ghanaian type 2 diabetes mellitus patients aged 20–70 years

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 10, Issue 1, 2016, Pages S79-S85

  Mogre, Victor ^a   Apala, Peter ^a   Nsoh, Jonas A ^a   Wanaba, Peter ^a  

^a UNIVERSITY FOR DEVELOPMENT STUDIES   (Ghana)

Author keywords

Abdominal obesity; Hypertension; Obesity; Type 2 diabetes; Weight management behaviours

Indexed keywords

GLUCOSE;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT MANAGEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES EDUCATION; DIABETIC HYPERTENSION; DIABETIC OBESITY; DIABETIC PATIENT; EXERCISE; FEMALE; GHANAIAN; GLUCOSE BLOOD LEVEL; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAL; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COUNSELING; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; STANDARD; WAIST CIRCUMFERENCE; BODY WEIGHT MAINTENANCE; COMPLICATION; DIABETES MELLITUS, TYPE 2; GHANA; HEALTH BEHAVIOR; HYPERTENSION; MIDDLE AGED; OBESITY; OVERWEIGHT; PROCEDURES; STATISTICS AND NUMERICAL DATA; WEIGHT LOSS PROGRAM; YOUNG ADULT; AGE; BLOOD PRESSURE; DIET RESTRICTION; HIP CIRCUMFERENCE; PATIENT CARE; WEIGHT REDUCTION;

ADIPOSITY; ADULT; AGED; BODY WEIGHT MAINTENANCE; DIABETES MELLITUS, TYPE 2; FEMALE; GHANA; HEALTH BEHAVIOR; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; WEIGHT REDUCTION PROGRAMS; YOUNG ADULT;

EID: 84949947504     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2015.09.022     Document Type: Article

References (74)

1. [1] IDF, IDF diabetes atlas. 6th ed., 2013, 1–159.
2. [2] WHO, Prevention of diabetes mellitus. 1994, WHO, Geneva.
3. [3] Rudy, D.R., Endocrinology. Rakel, R.E., (eds.) Textbook of family practice, 4th ed., 1990, WB Saunders Company, Philadelphia, 1082–1087.
4. [4] Crimmins, C.J., Approach to the patient with obesity. Gorol, A.H., (eds.) Primary care medicine, 2nd ed., 1987, JB Lippinicott Company, Philadelphia, 941–951.
5. [5] Vazquez, G., Duval, S., Jacobs, D.R., Silventoinen, K., Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 29 (2007), 115–128.
6. [6] Cheung, B.M., Li, C., Diabetes and hypertension: is there a common metabolic pathway?. Curr Atheroscler Rep 14 (2012), 160–166.
7. [7] Dupree, E.A., Meyer, M.B., Role of risk factors in complications of diabetes mellitus1. Am J Epidemiol 112 (1980), 100–112.
8. [8] Group, L.A.R., The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring, Md), 14, 2006, 737.
9. [9] Group DPPR, The diabetes prevention program: baseline characteristics of the randomized cohort. Diabetes Care, 23, 2000, 1619.
10. [10] Hall, V., Thomsen, R.W., Henriksen, O., Lohse, N., Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health, 11, 2011, 564.
11. [11] Cooper, R., Rotimi, C., Hypertension in blacks. Am J Hypertens 10 (1997), 804–812.
12. [12] Kengne, A.P., Amoah, A.G., Mbanya, J.-C., Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation 112 (2005), 3592–3601.
13. [13] WHO, WHO, (eds.) Obesity: preventing and managing the global epidemic, 2000, WHO, Geneva.
14. [14] WHO, Waist circumference and waist–hip ratio: report of a WHO expert consultation. 2008, WHO, Geneva.
15. [15] Seyum, B., Mebrahtu, G., Usman, A., Mufunda, J., Tewolde, B., Kosia, A., et al. Profile of patients with diabetes in Eritrea: results of first phase registry analyses. Acta Diabetol 47 (2010), 23–27.
16. [16] Danquah, I., Bedu-Addo, G., Terpe, K.J., Micah, F., Amoako, Y.A., et al. Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. BMC Public Health, 12, 2012, 210.
17. [17] Jasper, U., Magnitude of obesity, abdominal adiposity and their association with hypertension and diabetes-A cross sectional study. J Metabolic Synd 3 (2014), 1–6 2167-0943.1000146.
18. [18] Makuyana, D., Gomo, Z., Munyombwe, T., Matenga, J., Hakim, J., Metabolic syndrome disorders in urban black Zimbabweans with type 2 diabetes mellitus. Cent Afr J Med, 50, 2004, 24.
19. [19] Alebiosu, C.O., Odusan, B.O., Metabolic syndrome in subjects with type-2 diabetes mellitus. J Natl Med Assoc, 96, 2004, 817.
20. [20] Shirafkan, A., Marjani, A., Prevalence of obesity among type 2 diabetes mellitus in Gorgan (South East of Caspian Sea), Iran. World Appl Sci J 14 (2011), 1389–1396.
21. [21] Alwakeel, J.S., Sulimani, R., Al-Asaad, H., Al-Harbi, A., Tarif, N., et al. Diabetes complications in 1952 type 2 diabetes mellitus patients managed in a single institution in Saudi Arabia. Ann Saudi Med 28 (2007), 260–266.
22. [22] Kabakov, E., Norymberg, C., Osher, E., Koffler, M., Tordjman, K., et al. Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors. J Cardiometab Syndr 1 (2006), 95–101.
23. [23] Song, S., Hardisty, C., Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity. QJM 101 (2008), 875–879.
24. [24] Mulnier, H., Seaman, H., Raleigh, V., Soedamah-Muthu, S., Colhoun, H., et al. Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database. Diabetologia 49 (2006), 2859–2865.
25. [25] Hanefeld, M., Koehler, C., Gallo, S., Benke, I., Ott, P., Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardiovasc Diabetol, 6, 2007, 13.
26. [26] Poljičanin, T., Pavlić-Renar, I., Metelko, Ž, Obesity in type 2 diabetes: prevalence, treatment trends and dilemmas. Coll Antropol 35 (2011), 829–834.
27. [27] Suh, D.-C., Kim, C.-M., Choi, I.-S., Plauschinat, C.A., Barone, J.A., Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988-2004. J Hypertens 27 (2009), 1908–1916.
28. [28] Jiménez-Corona, A., Rojas, R., Gómez-Pérez, F.J., Aguilar-Salinas, C.A., Early-onset type 2 diabetes in a Mexican survey: results from the National Health and Nutrition Survey 2006. Salud Pública Méx 52 (2010), S27–S35.
29. [29] Thomas, M., Atkins, R., Assessment and management of hypertension in patients with type 2 diabetes. Intern Med J 39 (2009), 143–149.
30. [30] Moehlecke, M., Leitão, C.B., Kramer, C.K., Rodrigues, T.d.C., Nickel, C., et al. Effect of metabolic syndrome and of its individual components on renal function of patients with type 2 diabetes mellitus. Braz J Med Biol Res 43 (2010), 687–693.
31. [31] Wobeto, V.P.A., Pinho, P.d.C., Souza, J.R.M., Zaccariotto, T.R., Zonati, M.d.F., Haptoglobin genotypes and refractory hypertension in type 2 diabetes mellitus patients. Arq Bras Cardiol 97 (2011), 338–345.
32. [32] Ezenwaka, C.E., Offiah, N.V., Cardiovascular risk in obese and nonobese patients with type 2 diabetes in the west indies. J Biomed Sci 8 (2001), 314–320.
33. [33] Ogbera, A.O., Azenabor, A.O., Research hyperuricaemia and the metabolic syndrome in type 2 DM. 2010.
34. [34] Isezuo, S., Ezunu, E., Demographic and clinical correlates of metabolic syndrome in Native African type-2 diabetic patients. J Natl Med Assoc, 97, 2005, 557.
35. [35] Zoppini, G., Verlato, G., Leuzinger, C., Zamboni, C., Brun, E., et al. Body mass index and the risk of mortality in type II diabetic patients from Verona. Int J Obes 27 (2003), 281–285.
36. [36] Tariq, M., Hadi, A., Rahman, S.U., Metabolic syndrome in type-2 diabetics: an update on the silent epidemic. Rawal Med J 35 (2010), 201–204.
37. [37] Koehler, C., Ott, P., Benke, I., Hanefeld, M., Group, D.S., Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: the Diabetes in Germany (DIG) Study. Horm Metab Res 39 (2007), 632–635.
38. [38] Marchesini, G., Forlani, G., Cerrelli, F., Manini, R., Natale, S., et al. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet Med 21 (2004), 383–387.
39. [39] Klein, S., Allison, D.B., Heymsfield, S.B., Kelley, D.E., Leibel, R.L., et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity 15 (2007), 1061–1067.
40. [40] Meisinger, C., Döring, A., Thorand, B., Heier, M., Löwel, H., Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The MONICA/KORA Augsburg cohort study. Am J Clin Nutr 84 (2006), 483–489.
41. [41] Chan, D., Watts, G., Barrett, P., Burke, V., Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men. QJM 96 (2003), 441–447.
42. [42] Wang, Y., Rimm, E.B., Stampfer, M.J., Willett, W.C., Hu, F.B., Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81 (2005), 555–563.
43. [43] Mogre, V., Abedandi, R., Salifu, Z.S., Prevalence of obesity and systemic hypertension among diabetes mellitus patients attending an out-patient diabetes clinic in a Ghanaian Teaching Hospital. Diabetes Metab Syndr: Clin Res Rev 8:2 (2014), 67–71.
44. [44] Kengne, A.P., Limen, S.N., Sobngwi, E., Djouogo, C.F., Nouedoui, C., Metabolic syndrome in type 2 diabetes: comparative prevalence according to two sets of diagnostic criteria in sub-Saharan Africans. Diabetol Metab Syndr, 4, 2012, 22.
45. [45] Unadike, B., Eregie, A., Ohwovoriole, A., Prevalence of hypertension amongst persons with diabetes mellitus in Benin City, Nigeria. Niger J Clin Pract 14 (2011), 300–302.
46. [46] Choukem, S.P., Kengne, A.P., Dehayem, Y.M., Simo, N.L., Mbanya, J.C., Hypertension in people with diabetes in sub-Saharan Africa: revealing the hidden face of the iceberg. Diabetes Res Clin Pract 77 (2007), 293–299.
47. [47] Adler, A.I., Stratton, I.M., Neil, H.A.W., Yudkin, J.S., Matthews, D.R., et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321 (2000), 412–419.
48. [48] Group, U.P.D.S., Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ, 317, 1998, 703.
49. [49] Tsukinoki, R., Murakami, Y., Huxley, R., Ohkubo, T., Fang, X., et al. Does body mass index impact on the relationship between systolic blood pressure and cardiovascular disease? Meta-analysis of 419 488 individuals from the Asia Pacific cohort studies colaboration. Stroke 43 (2012), 1478–1483.
50. [50] Tseng, C.-H., Body mass index and blood pressure in adult type 2 diabetic patients in Taiwan. Circ J 71 (2007), 1749–1754.
51. [51] Nathan, D.M., Singer, D.E., Godine, J.E., Perlmuter, L.C., Non-insulin-dependent diabetes in older patients: complications and risk factors. Am J Med 81 (1986), 837–842.
52. [52] Turner, R.C., Cull, C.A., Frighi, V., Holman, R.R., Group, U.P.D.S., Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 281 (1999), 2005–2012.
53. [53] Mogre, V., Nyaba, R., Aleyira, S., Lifestyle risk factors of general and abdominal obesity in students of the School of Medicine and Health Science of the University of Development Studies, Tamale, Ghana. ISRN Obesity, 2014, 2014.
54. [54] Ross, C.E., Mirowsky, J., Social epidemiology of overweight: a substantive and methodological investigation. J Health Soc Behav 24 (1983), 288–298.
55. [55] Sobal, J., Rauschenbach, B.S., Frongillo, E.A. Jr., Marital status, fatness and obesity. Soc Sci Med 35 (1992), 915–923.
56. [56] Evers, S., Economic and social factors associated with obesity in adult Canadians. Nutr Res 7 (1987), 3–13.
57. [57] Wu, S., Wang, R., Jiang, A., Ding, Y., Wu, M., et al. Abdominal obesity and its association with health-related quality of life in adults: a population-based study in five Chinese cities. Health Qual Life Outcomes, 12, 2014, 100.
58. [58] Kittel, F., Rustin, R., Dramaix, M., De Backer, G., Kornitzer, M., Psycho-socio-biological correlates of moderate overweight in an industrial population. J Psychosom Res 22 (1978), 145–158.
59. [59] Shah, M., Jeffery, R., Hannan, P., Onstad, L., Relationship between socio-demographic and behaviour variables, and body mass index in a population with high-normal blood pressure: hypertension prevention trial. Eur J Clin Nutr, 43, 1989, 583.
60. [60] Horikawa, C., Kodama, S., Yachi, Y., Heianza, Y., Hirasawa, R., et al. Skipping breakfast and prevalence of overweight and obesity in Asian and Pacific regions: a meta-analysis. Prev Med 53 (2011), 260–267.
61. [61] Mesas, A., Muñoz-Pareja, M., López-García, E., Rodríguez-Artalejo, F., Selected eating behaviours and excess body weight: a systematic review. Obes Rev 13 (2012), 106–135.
62. [62] Rampersaud, G.C., Pereira, M.A., Girard, B.L., Adams, J., Metzl, J.D., Breakfast habits, nutritional status, body weight, and academic performance in children and adolescents. J Am Diet Assoc 105 (2005), 743–760.
63. [63] Szajewska, H., Ruszczyński, M., Systematic review demonstrating that breakfast consumption influences body weight outcomes in children and adolescents in Europe. Crit Rev Food Sci Nutr 50 (2010), 113–119.
64. [64] Dhurandhar, E.J., Dawson, J., Alcorn, A., Larsen, L.H., Thomas, E.A., et al. The effectiveness of breakfast recommendations on weight loss: a randomized controlled trial. Am J Clin Nutr 100:2 (2014), 507–513.
65. [65] Astbury, N.M., Taylor, M.A., Macdonald, I.A., Breakfast consumption affects appetite, energy intake, and the metabolic and endocrine responses to foods consumed later in the day in male habitual breakfast eaters. J Nutr 141 (2011), 1381–1389.
66. [66] Smeets, A.J., Westerterp-Plantenga, M.S., Acute effects on metabolism and appetite profile of one meal difference in the lower range of meal frequency. Br J Nutr 99 (2008), 1316–1321.
67. [67] Cahill, L.E., Chiuve, S.E., Mekary, R.A., Jensen, M.K., Flint, A.J., et al. Prospective study of breakfast eating and incident coronary heart disease in a cohort of male US health professionals. Circulation 128 (2013), 337–343.
68. [68] Stote, K.S., Baer, D.J., Spears, K., Paul, D.R., Harris, G.K., et al. A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults. Am J Clin Nutr 85 (2007), 981–988.
69. [69] Farshchi, H.R., Taylor, M.A., Macdonald, I.A., Deleterious effects of omitting breakfast on insulin sensitivity and fasting lipid profiles in healthy lean women. Am J Clin Nutr 81 (2005), 388–396.
70. [70] Jenkins, D.J., Wolever, T.M., Vuksan, V., Brighenti, F., Cunnane, S.C., et al. Nibbling versus gorging: metabolic advantages of increased meal frequency. N Engl J Med 321 (1989), 929–934.
71. [71] Mogre, V., Atibilla, J., Kandoh, B., Association between breakfast skipping and adiposity status among civil servants in the Tamale metropolis. J Med Biomed Sci 2 (2013), 1–7.
72. [72] Song, W.O., Chun, O.K., Obayashi, S., Cho, S., Chung, C.E., Is consumption of breakfast associated with body mass index in US adults?. J Am Diet Assoc 105 (2005), 1373–1382.
73. [73] van der Heijden, A.A., Hu, F.B., Rimm, E.B., van Dam, R.M., A prospective study of breakfast consumption and weight gain among U.S. men. Obesity (Silver Spring) 15 (2007), 2463–2469.
74. [74] Mekary, R.A., Giovannucci, E., Willett, W.C., van Dam, R.M., Hu, F.B., Eating patterns and type 2 diabetes risk in men: breakfast omission, eating frequency, and snacking. Am J Clin Nutr 95 (2012), 1182–1189.